Peapack-Gladstone Financial Corp’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,377
Closed -$197K 713
2023
Q3
$197K Sell
11,377
-12,783
-53% -$267K ﹤0.01% 644
2023
Q2
$502K Sell
24,160
-1,511
-6% -$32.8K 0.01% 483
2023
Q1
$605K Sell
25,671
-1,617
-6% -$43.4K 0.01% 442
2022
Q4
$762K Sell
27,288
-3,189
-10% -$81.5K 0.02% 409
2022
Q3
$714K Sell
30,477
-5,742
-16% -$173K 0.01% 404
2022
Q2
$1.22M Sell
36,219
-1,230
-3% -$43.1K 0.03% 329
2022
Q1
$1.31M Sell
37,449
-4,042
-10% -$138K 0.03% 340
2021
Q4
$1.26M Sell
41,491
-5,721
-12% -$186K 0.02% 352
2021
Q3
$1.55M Sell
47,212
-5,720
-11% -$183K 0.03% 310
2021
Q2
$1.6M Buy
+52,932
New +$1.74M 0.04% 273

Other funds holding OGN

Peapack-Gladstone Financial Corp's OGN Position: Q4 2023 in Review

Peapack-Gladstone Financial Corp sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 11,377 shares — an estimated $197K sold.

Peapack-Gladstone Financial Corp first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $1.6M in Q2 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Peapack-Gladstone Financial Corp reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Peapack-Gladstone Financial Corp sold 11,377 Organon & Co shares in Q4 2023, an estimated $197K.
  • Peapack-Gladstone Financial Corp first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Peapack-Gladstone Financial Corp's Organon & Co position peaked at $1.6M in Q2 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q4 2023, filed 13 Feb 2024.